Gene · 3866
Papers2,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women. | Cureus | 2023 | 37818522 | PubTator, text mining | PubMed |
| KRT15 in early breast cancer screening and correlation with HER2 positivity, pathological grade and N stage. | Biomark Med | 2023 | 37814985 | PubTator, text mining | PubMed |
| Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin. | Front Immunol | 2023 | 37809094 | PubTator, text mining | PubMed |
| Combining bioengineered human skin with bioprinted cartilage for ear reconstruction. | Sci Adv | 2023 | 37792948 | PubTator, text mining | PubMed |
| KSHV 3.0: A State-of-the-Art Annotation of the Kaposi's Sarcoma-Associated Herpesvirus Transcriptome Using Cross-Platform Sequencing. | bioRxiv | 2023 | 37790386 | PubTator, text mining | PubMed |
| Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin. | Front Immunol | 2023 | 37781383 | PubTator, text mining | PubMed |
| Unraveling the Role of Epithelial Cells in the Development of Chronic Rhinosinusitis. | Int J Mol Sci | 2023 | 37762530 | PubTator, text mining | PubMed |
| Immunohistochemical Staining Characteristics of Low-Grade Invasive Ductal Carcinoma Using the ADH5 Cocktail (CK5/14, P63, and CK7/18): A Potential Interpretative Pitfall. | Diagnostics (Basel) | 2023 | 37761331 | PubTator, text mining | PubMed |
| Human Oral Mucosa as a Potentially Effective Source of Neural Crest Stem Cells for Clinical Practice. | Cells | 2023 | 37759439 | PubTator, text mining | PubMed |
| Recent advances in exosomal non-coding RNA-based therapeutic approaches for photoaging. | Skin Res Technol | 2023 | 37753673 | PubTator, text mining | PubMed |
| Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors. | Clin Cancer Res | 2023 | 37747807 | PubTator, text mining | PubMed |
| Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis. | J Transl Med | 2023 | 37740179 | PubTator, text mining | PubMed |
| Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. | Nat Commun | 2023 | 37739939 | PubTator, text mining | PubMed |
| Defining E3 ligase-substrate relationships through multiplex CRISPR screening. | Nat Cell Biol | 2023 | 37735597 | PubTator, text mining | PubMed |
| Upregulation of Caveolae-Associated Proteins in Lesional Samples of Hidradenitis Suppurativa: A Case Series Study. | JID Innov | 2023 | 37731470 | PubTator, text mining | PubMed |
| epiAneufinder identifies copy number alterations from single-cell ATAC-seq data. | Nat Commun | 2023 | 37730813 | PubTator, text mining | PubMed |
| A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data. | Ann Med | 2023 | 37729607 | PubTator, text mining | PubMed |
| Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancer. | Oncol Lett | 2023 | 37720670 | PubTator, text mining | PubMed |
| Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer. | Front Pharmacol | 2023 | 37719843 | PubTator, text mining | PubMed |
| 3D bioprinting of corneal models: A review of the current state and future outlook. | J Tissue Eng | 2023 | 37719307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3866/papers?page=10